VDD could be an independent cardiovascular risk factor and a marker of metabolic syndrome [14], as per other existing biomarkers of metabolic syndrome and insulin resistance, such as “homeostasis model of assessment—insulin resistance” (HOMA-IR), levels of fasting insulin, fasting glycemia, C-reactive protein, fibrinogen, and lipid profile, among others [15]. This evidence concerns the gene CRP and Insulin resistance.